학술논문

TBX5 Variants are Associated with Susceptibility to and the Incidence of Liver Cirrhosis and Hepatocellular Carcinoma in the Chinese Population: A Multicenter and Follow-Up Study
Document Type
Academic Journal
Source
Infection and Drug Resistance. May 31, 2023, Vol. 16, p2653, 13 p.
Subject
China
Language
English
ISSN
1178-6973
Abstract
Purpose: Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) are progressions affected by genetic predispositions, and persistent hepatitis B virus infection also demonstrates genetic susceptibility. All HBV-related outcomes have been compared in parallel to identify risk polymorphism in HBV progression. Methods: The multiple-stage association study filtered and validated the risk SNPs for HBV progression and explored their association with persistent infection, with a total of 8906 subjects in China from three sites. Cox proportional hazards models and Kaplan-Meier Log rank tests were used to determine the time to the progressive event in relation to the risk SNPs. Results: Rs3825214 in TBX5 replicated a specific association with LC and HCC in 4 progression cohorts and was not related to persistent infection, naivety to HBV infection and natural clearance in 3 persistent cohorts. In combined samples, rs3825214 was associated with an increased risk of LC (P Conclusion: We identified and confirmed that genetic variants in TBX5 are significantly associated with susceptibility to and the incidence of LC and HCC. Keywords: TBX5, polymorphism, liver cirrhosis, hepatocellular carcinoma, follow- up, hepatitis B virus
Introduction Chronic hepatitis B virus (HBV) infection occurs worldwide but is endemic in East Asia and Africa, and the progression of chronic HBV infection includes liver cirrhosis (LC) and hepatocellular [...]